IPHA

Innate Pharma
IPHA

8 hedge funds and large institutions have $469K invested in Innate Pharma in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$45.6K
2
+$32.6K
3
+$169

Top Sellers

1
-$52.1K
2
-$41.9K
3
-$30.5K
4
Morgan Stanley
Morgan Stanley
New York
-$1.16K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$169K
2
$167K
3
$84.4K
4
$45.6K
5
$1K
6
$576
7
$397
8
$388
9
–
10
–